Novel Plasmodium antigens identified via genome-based antibody screen induce protection associated with polyfunctional T cell responses

Schussek, Sophie, Trieu, Angela, Apte, Simon h., Sidney, John, Sette, Alessandro, and Doolan, Denise L. (2017) Novel Plasmodium antigens identified via genome-based antibody screen induce protection associated with polyfunctional T cell responses. Scientific Reports, 7.

[img]
Preview
PDF (Published Version) - Published Version
Available under License Creative Commons Attribution.

Download (2MB) | Preview
View at Publisher Website: http://dx.doi.org/10.1038/s41598-017-153...
 
2
16


Abstract

The development of vaccines against complex intracellular pathogens, such as Plasmodium spp., where protection is likely mediated by cellular immune responses, has proven elusive. The availability of whole genome, proteome and transcriptome data has the potential to advance rational vaccine development but yet there are no licensed vaccines against malaria based on antigens identified from genomic data. Here, we show that the Plasmodium yoelii orthologs of four Plasmodium falciparum proteins identified by an antibody-based genome-wide screening strategy induce a high degree of sterile infection-blocking protection against sporozoite challenge in a stringent rodent malaria model. Protection increased in multi-antigen formulations. Importantly, protection was highly correlated with the induction of multifunctional triple-positive T cells expressing high amounts of IFN-gamma, IL-2 and TNF. These data demonstrate that antigens identified by serological screening are targets of multifunctional cellular immune responses that correlate with protection. Our results provide experimental validation for the concept of rational vaccine design from genomic sequence data.

Item ID: 51619
Item Type: Article (Refereed Research - C1)
Additional Information:

This article is licensedunder a Creative Commons Attribution 4.0 Internatinal License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and teh source, provide a link to the Creative Commons license, and indicate if changes were made. the images or other third party material in this article are included in the article's Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons license and yor intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission direclty from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.

ISSN: 2045-2322
Funders: University of Queensland (UQ), Australian Centre for Vaccine Development (ACVD), National Health and Medical Research Council (NHMRC), National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIH NIAID)
Projects and Grants: UQ International Research tuition Award, NHMRC Principal Research Fellowship, NHMRC Program Grant #1037304, NIH NIAID contract HHSN272200900044C, NIH Grant U19AI118626
Date Deposited: 22 Nov 2017 07:50
FoR Codes: 11 MEDICAL AND HEALTH SCIENCES > 1117 Public Health and Health Services > 111716 Preventive Medicine @ 50%
11 MEDICAL AND HEALTH SCIENCES > 1107 Immunology > 110704 Cellular Immunology @ 25%
11 MEDICAL AND HEALTH SCIENCES > 1107 Immunology > 110705 Humoural Immunology and Immunochemistry @ 25%
SEO Codes: 92 HEALTH > 9201 Clinical Health (Organs, Diseases and Abnormal Conditions) > 920109 Infectious Diseases @ 100%
Downloads: Total: 16
Last 12 Months: 4
More Statistics

Actions (Repository Staff Only)

Item Control Page Item Control Page